| Merck (Schweiz) AG - Campral, magensaftresistente Filmtabletten | | 53090 | | 01 | | Campral | | magensaftresistente Filmtabletten | | N07BB03 | | Acamprosate | | 29.08.1995 | | |
| | Composition | | acamprosatum 300 mg ut acamprosatum calcicum, crospovidonum, cellulosum microcristallinum, magnesii silicas, carboxymethylamylum natricum A corresp. natrium max. 0.42 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, talcum, propylenglycolum pro compresso obducto. | | Packungsbestandteile | | magensaftresistente Filmtabletten | | | | | Active Agent | Dose |
|---|
| Acamprosat | 300 mg |
| | BAG: Active Agent | Dose |
|---|
| Acamprosat | 300 mg |
| | | | Inactive agents | | additional_information |
|---|
| Acidi Methacrylici | | Überzug | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | Ethylis Acrylatis Polymerisatum | | | | Magnesii Silicas | | | | Magnesii Stearas | | | | Propylenglycolum pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
| |
| |
|
